Stay updated on Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has been updated to reflect the submission of results and has been revised to version 2.15.2, replacing the previous version 2.15.0.
    Difference
    0.3%
    Check dated 2025-04-30T14:22:41.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study descriptions and criteria for a clinical trial on Stage IV pancreatic cancer, while retaining key collaborators and the study's version number.
    Difference
    33%
    Check dated 2025-04-16T10:37:26.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 6, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.6%
    Check dated 2025-04-09T04:57:51.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-03-03T22:48:36.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    The page has been updated to reflect the ongoing study of nivolumab, cabiralizumab, and gemcitabine in patients with stage IV pancreatic cancer, including new dates and details about the trial's purpose and outcomes. Some previous information has been removed, indicating a shift in focus or status of the study.
    Difference
    14%
    Check dated 2025-02-10T15:30:49.000Z thumbnail image
  9. Check
    109 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T10:51:07.000Z thumbnail image

Stay in the know with updates to Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.